Entasis Therapeutics Announces Year End 2021 Financial Results and Provides Business Update

Provided By Globe Newswire

Last update: Mar 3, 2022

WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced full year 2021 financial results and provided a business update.